Nonmyeloablative Allogeneic Hematopoietic Transplantation: A Promising Salvage Therapy for Patients With Non-Hodgkin's Lymphoma Whose Disease Has Failed a Prior Autologous Transplantation We included ...

Suggestions of a significant relationship between chromosome abnormalities and tumor development came first from several German pathologists in the late nineteenth century 1. It was, however, the ...

July 1, 2009, New York, NY – Janet Davison Rowley, MD, a founder in the field of cancer cytogenetics and a renowned leader in molecular oncology, will receive the 2009 Genetics Prize of The Peter and ...

Joshua Richter, MD, assistant professor of medicine in The Tisch Cancer Institute, Division of Hematology and Medical Oncology, explains how the concept of cancer stage does not mean the same thing in ...

Karyotype analysis includes complete chromosome analysis of at least twenty metaphases with at least two cut karyotypes. The presence or absence of an acquired clonal chromosomal abnormality may aid ...

SAN DIEGO, March 23, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that the following top European institutions have recently incorporated the Saphyr ® system into ...

Multiple myeloma is a rare type of blood cancer that starts in your plasma cells. Your plasma cells are a type of white blood cell inside your bone marrow, the soft inner part of your bones. If you ...

Dublin, Sept. 17, 2019 (GLOBE NEWSWIRE) -- The "Cytogenetics - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report covers ...

The global demand for cytogenetic systems is set to experience substantial growth, with a market valuation projected to rise from USD 1,688.5 million in 2022 to USD 5,327.8 million by 2032. This 11.0% ...